The 2025 ASCO Annual Meeting brought groundbreaking advances and transformative developments to the oncology sphere. The event has long been a cornerstone for introducing innovative treatment paradigms and groundbreaking research in cancer therapy. This year, the conference sustained this trend by
Emerging research is offering new hope for millions suffering from chronic inflammation, a condition where the immune system's long-term response can damage healthy tissues. Identifying WSTF, a protein with a newly discovered role in chronic inflammation, has become a beacon for potential
With over ten million people worldwide battling Parkinson's disease, the quest for a treatment that not only controls symptoms but also halts the progression of this neurological disorder is of immense importance. Roche's recent advancement of prasinezumab, developed with Prothena, into Phase 3
In the swiftly changing world of biopharmaceuticals, the role of artificial intelligence (AI) is rapidly expanding, driving interest and speculation about its potential transformative effects on the industry. This landscape isn't just challenged by scientific demands but also by economic pressures,
The National Health Service (NHS) in England has been the subject of intense scrutiny and analysis as independent reviews seek to enhance patient safety amid complex bureaucratic layers. The recent report by Dr. Penny Dash delves into patient safety within the NHS, commissioned by the Department of
Breastfeeding has long been recognized not just as a timeless practice for nurturing infants but as a profound contributor to the health of both mothers and their children. In recent times, the spotlight has shifted toward breastfeeding's potential in reducing the risk of breast cancer and other
